Heterogeneity of Lung Ventilation Determined by EIT During PFT in Patients With PRISM
1 other identifier
observational
200
1 country
1
Brief Summary
To evaluate the demographic characteristics of PRISm population in patients with pulmonary function tests recommended by outpatient physicians. To investigate whether EIT can identify spatial and temporal heterogeneity of lung ventilation in individuals with PRISm during pulmonary function testing. To investigate the distribution patterns of lung ventilation in individuals with PRISm using this technique, and provide references and evidence for early screening, diagnosis, treatment monitoring, and prognostic evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2023
CompletedFirst Submitted
Initial submission to the registry
December 27, 2023
CompletedFirst Posted
Study publicly available on registry
January 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedMay 8, 2024
May 1, 2024
1.1 years
December 27, 2023
May 5, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
GI
EIT parameters
one month
time constant time constant in second
EIT parameters
one month
abnormal area in percent time constant in second
EIT parameters
one month
Study Arms (3)
Normal lung function
Normal lung function: After using a bronchodilator, FEV1/FVC ≥70%, FEV1 and FVC ≥80% of reference values.
Preserved ratio impaired spirometry
After using a bronchodilator, FEV1/FVC≥70%, FEV1 and/or FVC\<80% of reference values.
Chronic obstructive pulmonary disease
After using a bronchodilator, FEV1/FVC \<70%.
Interventions
pulmonary function testing
Eligibility Criteria
Gender, age, height, weight, smoking history, reason for seeking medical care, medication history, history of oxygen therapy, comorbidities.
You may qualify if:
- Age ≥18 years old. Patients who need to complete lung function tests assessed by outpatient physicians.
- Patients willing to participate in the study and sign an informed consent form.
You may not qualify if:
- Patients with a history of lung diseases other than COPD, previous lung surgery, or radiation therapy.
- Patients who cannot be evaluated for EIT or who interfere with EIT results, such as implanted pacemakers/cardioverters.
- Patients who cannot complete EIT or may interfere with EIT results, such as those with implanted pacemakers/defibrillators.
- Patients who cannot complete lung function tests, such as myocardial infarction or shock in the past 3 months; severe heart failure or angina in the past 4 weeks,uncontrolled hypertension (systolic \>200mmHg, diastolic \>100mmHg),severe hyperthyroidism etc.
- Vulnerable populations, including patients with mental illnesses, cognitive impairments, critically ill patients, illiterate, pregnant women, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, 310000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Huiqing Ge
Sir Run Run Shaw Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 27, 2023
First Posted
January 10, 2024
Study Start
December 5, 2023
Primary Completion
December 31, 2024
Study Completion
July 1, 2025
Last Updated
May 8, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share